CLINICAL_TRIALS
trial_result
· 2019-11-01
Clinical Trial Update: A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects [Phase 1]
Summary
Phase 1 safety and pharmacokinetic study of GSK2982772 in healthy subjects completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Autoimmune Diseases | Phase 1 | Status: COMPLETED | Results posted: 2019-11-01